MCK Q4 2022 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q4 2022 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$66.1B+11.8% YoY

Gross Profit

$3.2B4.9% margin

Operating Income

$787M1.2% margin

Net Income

$368M0.6% margin

EPS (Diluted)

$2.47

QoQ Revenue Growth

-3.7%

Cash Flow

Operating Cash Flow

$2.9B

Free Cash Flow

$2.7B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$63.3B

Total Liabilities

$65.1B

Stockholders' Equity

-$2.3B

Cash & Equivalents

$3.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$66.1B	$59.1B	+11.8%
Gross Profit	$3.2B	$3.2B	+1.9%
Operating Income	$787M	$1.1B	-29.0%
Net Income	$368M	$666M	-44.7%

Revenue Segments

U.S. Pharmaceutical Segment

$53.7B81%

International Segment

$8.5B13%

Medical-Surgical Solutions Segment

$2.9B4%

Prescription Technology Solutions

$1.0B2%